SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
29 hedge funds and large institutions have $58.8M invested in Sinovac Biotech, Ltd in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
29
Holding in Top 10
1
Calls
$669K
Puts
–
Top Buyers
| 1 | +$923K | |
| 2 | +$412K | |
| 3 | +$259K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$98.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$66K |
Top Sellers
| 1 | -$575K | |
| 2 | -$544K | |
| 3 | -$412K | |
| 4 |
Two Sigma Investments
New York
|
-$295K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$218K |